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The staphylococcal virulon is activated by the density-sensing agr system, which is autoinduced by a short
peptide (autoinducing peptide [AIP]) processed from a propeptide encoded by agrD. A central segment of the
agr locus, consisting of the C-terminal two-thirds of AgrB (the putative processing enzyme), AgrD, and the
N-terminal half of AgrC (the receptor), shows striking interstrain variation. This finding has led to the division
of Staphylococcus aureus isolates into three different agr specificity groups and to the division of non-aureus
staphylococci into a number of others. The AIPs cross-inhibit the agr responses between groups. We have
previously shown that most menstrual toxic shock strains belong to agr specificity group III but that no strong
clinical identity has been associated with strains of the other two groups. In the present report, we demonstrate
a fourth agr specificity group among S. aureus strains and show that most exfoliatin-producing strains belong
to this group. A striking common feature of group IV strains is activation of the agr response early in expo-
nential phase, at least 2 h earlier than in strains of the other groups. This finding raises the question of the
biological significance of the agr autoinduction threshold.
The agr locus (Fig. 1) regulates the production of most
staphylococcal exoproteins, including exoenzymes, toxins, sur-
face proteins, and other virulence factors, by means of a den-
sity-dependent autoinducible signal transduction system driven
by a short posttranslationally processed peptide (autoinducing
peptide [AIP]) (4). Autoinduction activates synthesis of a
0.5-kb highly conserved agr transcript, RNAIII, that is the
actual effector of exoprotein gene regulation (10). Although
the agr locus is conserved throughout staphylococci, the auto-
induction circuit, consisting of the signal receptor AgrC, the
AIP, processed from AgrD, and the putative AIP processing-
secretion protein AgrB, shows striking sequence variation (see
the hypervariable region in Fig. 1), which serves to define
distinct specificity groups (5). Within any one group, these
sequences are highly conserved and mutual cross-activation is
observed. Between groups, however, there is mutual cross-
inhibition of the agr signaling pathway (5), giving rise to a novel
type of bacterial interference that may have a role in coloni-
zation and/or infection. In an earlier study (5), three distinct
agr specificity groups of Staphylococcus aureus strains were
defined on the basis of mutual cross-inhibition of agr function,
and we and others have observed that coagulase-negative
staphylococcal species produce an additional series of variant
peptides (12, 14; unpublished data). Those that have been ex-
FIG. 1. S. aureus agr locus. At the top is a schematic diagram of a shuttle vector, pRN7062, containing two segments of the agr locus, agrA plus agrC and the P2-P3
region, and below is a diagram of the agr locus, as described in the text, showing the approximate locations of the segments used in the vector. DSO, double-strand
origin; SSO, single-strand origin; MCS, multiple cloning site; HPK, histidine protein kinase.
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amined inhibit agr expression in all three S. aureus groups (12;
unpublished data).
Surveys of naturally occurring S. aureus isolates, by dot blot
hybridization using agr group-specific DNA probes based on
divergent regions of agrC (5), have revealed several strains that
do not belong to any of the three known groups. The chromo-
somal DNAs of these strains did not hybridize with any of the
three group-specific probes. Many of these strains produce
exfoliatin (ET), a toxin that is responsible for staphylococcal
scalded-skin syndrome (6, 8). In earlier studies, we have not
detected ET production among strains of the three known
groups. In this report, we present data demonstrating a fourth
agr specificity group in S. aureus, associated with ET produc-
tion, and show that occasional strains belonging to the previ-
ously defined agr specificity groups I and II also produce ET.
To begin the characterization of ET-producing strains that
did not belong to agr groups I to III, we tested several for the
production of agr AIPs. In this test a post-exponential-phase
culture supernatant is added to an early-exponential-phase
culture of the same strain and induction of RNAIII synthesis is
evaluated by Northern hybridization, now a standard test for
agr autoinduction (4). In Fig. 2A we show a Northern hybrid-
ization pattern demonstrating a positive result in this test,
using strain RN4850, a typical ET producer. Note that al-
though the bacteria used for this test were at a very early stage
in exponential-phase growth, at a cell density of ;5 3 107/ml,
there was already a substantial RNAIII signal. In strains of the
three existing groups, there is generally no detectable RNAIII
signal until 2 to 3 h later, in mid-exponential phase (A. M. S.
Figueiredo, H. F. Ross, Y. Fang, and R. P. Novick, submitted
for publication). The early RNAIII signal suggested that
RNAIII timing might differ among these strains, and a time
course of RNAIII expression revealed that this is indeed the
case, as shown in Fig. 3A. Here, the results for the ET strain
RN4850 are compared with the time course for a typical group
I strain, RN7690 (Figueiredo et al., submitted). As can be seen,
the onset of RNAIII synthesis in the former was at a cell
density between 1.5 3 107 and 3 3 107/ml, occurring nearly 3 h
earlier than in the group I strain. This difference was paralleled
by differences in the times of onset of transcription of two
agr-regulated genes, hla (a-hemolysin) and spr (V8 serine pro-
tease), and the blot also revealed another difference, namely,
FIG. 2. Activation and inhibition of RNAIII transcription in agr group IV
strains by culture supernatants. Early-exponential-phase bacteria (5 3 107 cells/
ml, strain RN4850, lanes 1, 3, 5, and 6, or RN4846, lanes 2 and 4) were treated
with Casamino Acids-yeast extract broth (lanes 1, 2, and 5), with supernatant
from post-exponential-phase cells of the same strain (lanes 3 and 4), or with
supernatant from a group II strain (RN6607) (lane 6). Whole-cell RNA samples
were prepared after 1 h (lanes 1 to 4) or after 80 min (lanes 5 and 6) (5) and
analyzed by Northern hybridization with an RNAIII-specific probe.
FIG. 3. Timing of RNAIII, a-hemolysin (hla) and serine protease (spr) gene
transcription. Cultures were started in early exponential phase (5 3 107 cells/ml),
and samples were removed at hourly intervals for determination of cell density
and for preparation of whole-cell RNA for Northern hybridization analysis. The
amount of RNA in each sample was normalized to that of the rRNA, which was
quantitated by scanning an ethidium bromide-stained agarose gel with an Alpha-
Inotech video-imager. (A) Growth curves of RN4850 and RN7690. Cell densities
(optical densities [OD]) were measured with a Molecular Devices microplate
reader at 650 nm. (B and C) Northern hybridization analysis using a probe
specific for RNAIII, hla, or spr. The arrow indicates the full-sized transcript
containing the gene.
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the presence of a second spr transcript, much smaller than the
full-sized transcript containing the gene. This second spr tran-
script was seen in other group IV strains but not in strains of
the other groups (Figueiredo et al., submitted). It has not been
characterized further.
Tests for autoinduction specificity involved determinations
of agr activation and inhibition activity by each of the existing
groups toward the ET strains. For these tests, we used different
plasmid constructs, each containing agrAC from one of the
four groups, and introduced each of these into an agr-null
derivative of the standard strain from which the agrAC region
was cloned (Figueiredo et al., submitted), along with a second
plasmid containing an agr-P3::blaZ fusion (Lyon et al., submit-
ted for publication). A diagram of one of these constructs,
pRN7062, is shown in Fig. 1 (top), and a list of the strains and
plasmids used is presented in Table 1. With these strains,
b-lactamase is produced only when agrAC signaling is induced
by the autologous AIP, added externally, and inhibition of this
response can be demonstrated by the simultaneous addition of
autologous and heterologous AIPs. Thus, AIP activities could
FIG. 4. agr activation and inhibition by culture supernatants. (A and B) One-tenth volume of a post-exponential-phase culture supernatant (sup) or CY broth was
added to mid-exponential-phase cultures, growth was continued for an additional hour with shaking at 37°C, and samples were then assayed for b-lactamase by the
nitrocefin method (11) as adapted for the microplate reader (4). The group I supernatant was from RN6734, the group II supernatant was from RN6607, the group
III supernatant was from RN8465, and the group IV supernatant was from RN4850. Note that b-lactamase activity in samples treated with group III supernatant
(cross-hatched bars) represents the endogenous b-lactamase activity of the group III strain and does not represent activation of group IV. (C) Northern hybridization
analysis of the effects of the RN4850 (group IV) supernatant on agr activation in RN8465 (group III). One-tenth volume of a post-exponential-phase RN4850
supernatant (1) or broth (2) was added to a mid-exponential-phase culture of RN8465, and hourly samples were taken for Northern hybridization analysis using an
RNAIII-specific probe.
TABLE 1. Strains and plasmids
Strain Plasmid Description Reference
RN6734 Group I prototype, derived from NTCT8325 2
RN7690 Group I prototype (V8 serine protease strain) 1
RN6607 Group II prototype (strain 502A) 5
RN8465 Group III prototype (menstrual toxic shock syndrome strain)a
RN4846 Group IV prototype (ET producer) University of Minnesota strain TAa
RN4850 Group IV prototype (ET producer) University of Minnesota strain KGa Figueiredo et al., submitted
RN5881 Group IV prototype This work
RN7206 Group I prototype, RN6734, with tetM replacing agr (agr null) 10
RN9365 pRN7062 RN7206 with shuttle vector containing group I agrAC and the agr-P3::blaZ fusion Lyon et al., submitted
RN9120 Group II prototype, RN6607, with tetM replacing agr (agr null) Figueiredo et al., submitted
RN9372 pRN7105 RN9120 with the shuttle vector containing group II agrAC and the agr-P3::blaZ fusion Lyon et al., submitted
RN9121 Group IV prototype, RN4850, with tetM replacing agr (agr null) Figueiredo et al., submitted
RN9371 pRN7107 RN9121 with the shuttle vector containing group IV agrAC and the agr-P3::blaZ fusion Lyon et al., submitted
a Kindly provided by Patrick Schlievert.
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be tested without interference from the endogenous peptides
(4). This strategy, however, could not be used for agr group III,
as all of our group III strains possess a chromosomal b-lacta-
mase gene (unpublished data). As shown in Fig. 4A, there was
no detectable RNAIII activation in cultures of RN9371 (the
agr-null derivative of RN4850 containing cloned RN4850
agrAC) treated with supernatants from strains of each of the
three known groups, whereas there was a strong signal in the
RN9371 culture treated with the autogenous (RN4850) super-
natant. The group II and III supernatants inhibited activation
by the RN4850 supernatant, as is usually the case with heter-
ologous AIPs (5). The group I supernatant, however, did not
inhibit agr activation by RN4850 (group IV) supernatant. Con-
versely, as shown in Fig. 4B and C, the RN4850 supernatant
inhibited RNAIII production by the standard strains of groups
II and III; however, it did activate the group I strain to ap-
FIG. 5. Comparisons of the predicted AgrD (A) and partial AgrC (B) products from S. aureus groups I to IV, Staphylococcus epidermidis, and Staphylococcus
lugdunensis. The sequences were aligned with the CLUSTAL X software. The sequences are as follows: S. aureus group IV (GeneBank accession number AF288215),
group I (GeneBank accession number U85097) (9), group II (GeneBank accession number AF001782), and group III (GeneBank accession number AF001783) and
S. epidermidis (Z49220) (Se) (14) and S. lugdunensis (Sl) (GeneBank accession number AF173933). A 1 indicates a stop codon. All other marks were generated by
CLUSTAL X; dashes indicate gaps, asterisks indicate fully conserved residues, and colons and periods, respectively, indicate strongly and weakly similar amino acid
groups according to the software. AIP sequences are indicated in boldface.
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proximately 30% of the level seen with the group I superna-
tant. These results were confirmed for groups I and II with
synthetic AIPs (7). Because of its endogenous b-lactamase, the
group III strain was tested by Northern hybridization (Fig. 4C)
and showed strong inhibition of agr activation by the RN4850
supernatant.
To confirm the identification of a new agr group, we deter-
mined the sequences of the agr loci for five different ET-
producing strains, including RN4850. Two primers (AGR-1,
59-ATG CAC ATG GTG CAC ATG CA [forward], and
AGR-2, 59-CAT AAT CAT GAC GGA ACT TGC TGC GCA
[reverse]) were designed, according to conserved regions for
the three agr groups of S. aureus (GenBank accession numbers
M21854, AF001782, and AF001783), to provide specific am-
plification of an ;1.2-kb fragment that included the 39 end of
agrB, all of agrD, and the 59 end of agrC. The five sequences
obtained with these different ET-producing strains were essen-
tially identical to one another but differed in typical ways from
agr sequences for strains of the other three groups, as shown in
Fig. 5. In particular, the predicted AIP sequences were differ-
ent from those of the other three groups, although, interest-
ingly, there was only a single difference between these and the
group I AIP, namely, a replacement of aspartic acid for ty-
rosine. Additionally, the predicted amino acid sequence of the
N-terminal half of group IV AgrC was also close to that of
group I agrC (Fig. 5B). It is concluded that the ET-producing
strains define a new S. aureus agr group, group IV. The group
IV agr locus is most closely related to that of group I, consistent
with the observed weak activation of the group I strain by the
group IV supernatant. Interestingly, the group IV strains be-
long to phage group II, which is generally regarded as distant
from the other two phage groups.
The possible link between agr group IV and ET production
was analyzed with a larger collection of strains by determining
the sequence of the agr loci of 15 other ET-producing strains
using the method described above. As shown in Table 2, 8 of 15
isolates belong to agr group IV, 2 belong to group I, and 5
belong to group II. It was concluded that while the majority of
ET-producing strains were of agr group IV, there was no
absolute correlation between ET production and agr group.
The kinetics of RNAIII expression in three ET-producing
strains belonging to agr groups I (strain A970675), II (strain
A970545), and IV (strain A930309) were compared by North-
ern hybridization. Confirming the results obtained with strain
RN4850, the onset of RNAIII synthesis in agr group IV strain
A930309 was at a cell density between 106 and 107 CFU/ml
(not shown). However, the timing of agr expression in the
group I and II ET-producing strains (Fig. 3B) was typical of
that in other strains of these two groups (Figueiredo et al.,
submitted), suggesting that early RNAIII expression is a prop-
erty of agr group IV strains and not necessarily of ET-produc-
ing strains.
To investigate the molecular basis of the early expression of
RNAIII by the agr group IV strains, we amplified and se-
quenced the agr-P2-P3 intergenic region and most of the
RNAIII-determining region (511 nucleotides) of agr groups II
(strains A970545 and A960463) and IV (strains A930309 and
A940384), using primers GL-1 (59-GCC GCG AGC TTG
GGA G [forward]) and GL-2 (59-GAA GAT ACG TGG CAA
ACT GGT C [reverse]). Comparison of the resulting se-
quences with that of agr group I strain (3) (10) revealed that
they were highly similar to each other. Indeed, the RNAIII
region, the putative P2 and P3 promoter region, and sar-bind-
ing sites showed no sequence variation. However, we observed
differences in the 235 consensus sequences of promoter P3
between agr groups I (TTGGAA), II (ATCGAA), and IV
(ATGGAA) that may account for differential initiation fre-
quencies (2). At this point we can hypothesize that the 235
region of the P3 promoter, and/or the amino acid sequences of
the AIP and of AgrC, may contribute to the early and strong
expression of RNAIII in these strains.
The majority of ET producers belong to group IV, and ET
production is known to be positively regulated by agr (13).
Although there seemed initially to be a correlation between
early and strong RNAIII expression in vitro and the produc-
tion of ET, the finding that ET-producing strains of other agr
groups express RNAIII in a manner similar to those of other
strains of these groups suggests that the difference in the tim-
ings of RNAIII expression among the agr groups cannot rep-
resent any pathobiological necessity for early ET expression.
Nucleotide sequence accession number. The agr sequence
for group IV strain RN5881 has been deposited in GenBank
(accession no. AF288215).
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